Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 23 (7), 1417-50

Nanotechnology: Intelligent Design to Treat Complex Disease

Affiliations
Review

Nanotechnology: Intelligent Design to Treat Complex Disease

Patrick Couvreur et al. Pharm Res.

Abstract

The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the "magic bullet" proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.

Similar articles

See all similar articles

Cited by 86 PubMed Central articles

See all "Cited by" articles

References

    1. J Drug Target. 1994;2(5):351-6 - PubMed
    1. FEBS Lett. 1991 Jun 24;284(2):263-6 - PubMed
    1. J Immunol. 2004 Sep 1;173(5):3148-54 - PubMed
    1. Pharm Res. 2003 Aug;20(8):1249-57 - PubMed
    1. Hum Gene Ther. 1997 Jul 1;8(10 ):1243-51 - PubMed

MeSH terms

LinkOut - more resources

Feedback